IFN-beta and EIF2AK2 are potential biomarkers for interstitial lung disease in anti-MDA5 positive dermatomyositis.

Yiming LiuShuo FengXingyue LiuYujie TangXiaoling LiChengyu LuoJin-Hui Tao

Published in: Rheumatology (Oxford, England) (2023)

IFN-beta and EIF2AK2 contributed to the pathogenesis of MDA5+ DM-ILD, which could be used as potential therapeutic targets.

Keyphrases